BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17599040)

  • 21. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
    Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
    Su N; Qiu H; Chen Y; Yang T; Yan Q; Wan X
    Oncol Rep; 2013 Jun; 29(6):2297-302. PubMed ID: 23589079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
    Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
    Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of the FOXO1, KLF9 and YT521 genes expression in human endometrial cancer.
    Korani M; Fallah S; Tehranian A; Nourbakhsh M; Samadikuchaksaraei A; Pour MS; Maleki J
    Clin Lab; 2013; 59(5-6):483-9. PubMed ID: 23865345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
    Haughian JM; Bradford AP
    J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
    Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
    Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway.
    Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P
    Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.
    Takano M; Lu Z; Goto T; Fusi L; Higham J; Francis J; Withey A; Hardt J; Cloke B; Stavropoulou AV; Ishihara O; Lam EW; Unterman TG; Brosens JJ; Kim JJ
    Mol Endocrinol; 2007 Oct; 21(10):2334-49. PubMed ID: 17609436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
    Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
    Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization.
    Kajihara T; Jones M; Fusi L; Takano M; Feroze-Zaidi F; Pirianov G; Mehmet H; Ishihara O; Higham JM; Lam EW; Brosens JJ
    Mol Endocrinol; 2006 Oct; 20(10):2444-55. PubMed ID: 16709600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel wnt regulatory axis in endometrioid endometrial cancer.
    Zhao Y; Yang Y; Trovik J; Sun K; Zhou L; Jiang P; Lau TS; Hoivik EA; Salvesen HB; Sun H; Wang H
    Cancer Res; 2014 Sep; 74(18):5103-17. PubMed ID: 25085246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
    Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
    Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.